Dual delivery of nucleic acids and PEGylated-bisphosphonates via calcium phosphate nanoparticles
- 1 September 2019
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 142, 142-152
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Singapore Eye Research Institute (642028)
- Staatssekretariat für Bildung, Forschung und Innovation
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2015-05364)
This publication has 56 references indexed in Scilit:
- Biomedical applications of bisphosphonatesJournal of Controlled Release, 2013
- Mechanisms of action of bisphosphonates in oncology: a scientific concept evolving from antiresorptive to anticancer activitiesBoneKEy Reports, 2013
- Facile preparation of heparin/CaCO3/CaP hybrid nano-carriers with controllable size for anticancer drug deliveryColloids and Surfaces B: Biointerfaces, 2013
- Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumorJournal of Controlled Release, 2012
- The effect of sedimentation and diffusion on cellular uptake of gold nanoparticlesNature Nanotechnology, 2011
- Gene delivery with bisphosphonate-stabilized calcium phosphate nanoparticlesJournal of Controlled Release, 2011
- Breathing Life into Polycations: Functionalization with pH-Responsive Endosomolytic Peptides and Polyethylene Glycol Enables siRNA DeliveryJournal of the American Chemical Society, 2008
- A dimethylmaleic acid–melittin‐polylysine conjugate with reduced toxicity, pH‐triggered endosomolytic activity and enhanced gene transfer potentialThe Journal of Gene Medicine, 2007
- Nitrogen-Containing Bisphosphonates as Carbocation Transition State Analogs for Isoprenoid BiosynthesisBiochemical and Biophysical Research Communications, 1999
- Hydroxyapatite/polyacrylic acid nanocrystalsJournal of Materials Chemistry, 1999